Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2017-02-15 Board/Management Inform…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Clinical Marketing Manager is joining Episurf Medical
Board/Management Information Classification · 99% confidence The document is a 'Company Announcement' dated February 15, 2017, detailing the hiring of a new Clinical Marketing Manager, Davide Masoni. This announcement concerns a change in senior personnel within the company's management structure. According to the definitions, the 'Board/Management Information (Code: MANG)' category covers the 'Announcement of changes in the company's board of directors or senior management.' The final paragraph confirms this is an official announcement required under EU Market Abuse Regulation, making it a formal corporate disclosure related to management changes. Therefore, MANG is the most appropriate classification.
2017-02-15 English
Episurf Medical erhåller sina första beviljade patent i Kina
Regulatory Filings Classification · 95% confidence The document is a press release dated February 14, 2017, announcing that Episurf Medical has received approval for two new patents in China related to surgical tools. This announcement concerns intellectual property rights and technological protection. Among the provided categories, 'LTR' (Legal Proceedings Report) is the closest fit as it covers significant legal matters, which often includes intellectual property disputes or grants, although 'LTR' usually implies litigation. However, none of the other categories fit well: it is not an earnings release (ER), a capital change (CAP/SHA), a management change (MANG), or a general regulatory filing (RNS) that doesn't fit elsewhere. Since patent grants are a form of legal/IP protection announcement, and given the specific nature of the news (patent approval), I will classify it as 'LTR' (Legal Proceedings Report) as the best available fit for significant legal/IP news, although 'RNS' (Regulatory Filings) is a strong secondary candidate if 'LTR' is strictly interpreted as litigation. Given the context of securing IP protection, LTR is chosen over the general RNS fallback.
2017-02-14 Swedish
Episurf Medical obtains its first granted patents in China
Investor Presentation Classification · 98% confidence The document is a 'Company Announcement' dated February 14, 2017, detailing that Episurf Medical has obtained its first granted patents in China related to surgical tools and implants. This content directly relates to the company's intellectual property (IP) portfolio and technological assets. Reviewing the definitions, the category 'Intellectual Property' (IP) is the most appropriate fit, as the core subject is the granting of patents. It is not an ER (Earnings Release), IR (Interim Report), 10-K (Annual Report), or CT (Call Transcript). It is a specific announcement about IP protection, making 'IP' the correct classification over the general 'RNS' fallback.
2017-02-14 English
Episurf Medical AB presenterar vid ProHearings den 17 februari i Stockholm
Regulatory Filings Classification · 95% confidence The document is a short press release dated February 9, 2017, announcing that Episurf Medical AB will present at an investor event called 'ProHearings' on February 17th in Stockholm. It mentions the CEO/CFO will represent the company and that the presentation will be available on the company website. Since this is an announcement about participation in an investor meeting/presentation, and not the presentation itself, the most fitting category is 'Investor Presentation' (IP) if the content is the presentation, or 'Report Publication Announcement' (RPA) if it's just announcing the event/availability. Given the context of investor relations and the nature of such announcements, it strongly relates to investor engagement. However, since the document itself is an announcement of participation in an event where a presentation will be given, and it is very short (1632 chars), it fits the description of an announcement rather than the full report/presentation. If the presentation material itself were attached, it would be IP. As it is an announcement about an upcoming presentation at an investor meeting, it is best classified as a general regulatory announcement or an announcement related to investor engagement. Given the options, and that it is a specific announcement about an investor event, it is closest to an Investor Presentation (IP) announcement, but following the 'MENU VS MEAL' rule, a short announcement about a future presentation is often categorized as a general regulatory filing (RNS) or an announcement of publication (RPA) if it were announcing the release of a report. Since this is an announcement about *attending* an event where a presentation will be given, and it is not a standard regulatory form, RNS is the most appropriate fallback for specific investor/corporate event announcements that don't fit other categories like DIV or DIRS. However, since the event is an investor meeting, and the document is essentially a notice about investor engagement, I will lean towards RNS as the general regulatory announcement category for this type of corporate news.
2017-02-09 Swedish
Episurf Medical AB to present at ProHearings, held in Stockholm on February 17
Regulatory Filings Classification · 95% confidence The document is a short company announcement dated February 8, 2017, stating that Episurf Medical AB will present at an investor meeting called 'ProHearings' on February 17. It provides details about the event, the representative (acting CEO/CFO), and directs readers to a link for the full program and registration. It also mentions that the presentation will be available on the company's website. Since this is an announcement about an upcoming presentation/event rather than the presentation itself, and it doesn't fit the specific definitions for ER, CT, or IP (which are usually the presentation/call content), it best fits the category for announcing the publication or availability of company information or events. Given the short length and the nature of announcing an event where a presentation will be given, 'Report Publication Announcement' (RPA) is the most appropriate fit, as it signals the upcoming release of presentation material, or 'Regulatory Filings' (RNS) if it's a general mandatory disclosure. However, since it is specifically announcing participation in an investor event where material will be shared, and it is not the actual presentation (IP) or a transcript (CT), RPA is a strong candidate for an announcement about future material release. Given the options, and the fact that it is a general company announcement about an investor event, RNS (Regulatory Filings - general fallback) is also plausible, but RPA covers announcements about the publication of reports/presentations better. Since it's an announcement about an investor presentation, IP (Investor Presentation) is for the presentation itself. This is an announcement *about* the presentation. I will classify this as RPA because it announces an event where company material will be presented/published, fitting the spirit of announcing a report/presentation release.
2017-02-09 English
Episurf Medical ställer ut vid AAOS 2017 i San Diego, Kalifornien
Regulatory Filings Classification · 95% confidence The document is a short press release dated February 8, 2017, announcing that Episurf Medical AB will be exhibiting at the American Academy of Orthopaedic Surgeons (AAOS) 2017 annual meeting. It details the event, the company's participation, and contact information. It is not a formal financial report (like 10-K, IR, ER), a management change announcement (MANG), or a dividend notice (DIV). Since it is a general announcement about company activity (exhibiting at a major industry event) that doesn't fit neatly into the specific financial or governance categories, it best fits the general regulatory announcement/miscellaneous category, which is RNS (Regulatory Filings). Given the very short length and nature as a press release, RNS is the most appropriate fallback.
2017-02-08 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.